DART PHARMA Trademark

Trademark Overview

On Saturday, September 14, 2013, a trademark application was filed for DART PHARMA with the United States Patent and Trademark Office. The USPTO has given the DART PHARMA trademark a serial number of 86064943. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, July 13, 2018. This trademark is owned by Dart NeuroScience, LLC. The DART PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and technological research in the fields of the development of gene discovery, gene network informatics, drug discovery, and chemistry to identify small molecules and pharmaceuticals for use in treating various brain disorders and for maintaining and enhancing normal brain function; Scientific research and development, namely, development of scientific methods to diagnose functional deficits, including motor and cognitive deficits, in various brain domains, and to rehabilitate those domains with effective brain exercises and training protocols in combination with drugs and pharmaceuticals; Scientific research and development, namely, development of scientific methods to enhance brain function, including motor and cognitive functions, in specific brain domains by combining effective brain exercises and training protocols with drugs and pharmaceuticals
dart pharma

General Information

Serial Number86064943
Word MarkDART PHARMA
Filing DateSaturday, September 14, 2013
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, July 13, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2014

Trademark Statements

Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesScientific research and technological research in the fields of the development of gene discovery, gene network informatics, drug discovery, and chemistry to identify small molecules and pharmaceuticals for use in treating various brain disorders and for maintaining and enhancing normal brain function; Scientific research and development, namely, development of scientific methods to diagnose functional deficits, including motor and cognitive deficits, in various brain domains, and to rehabilitate those domains with effective brain exercises and training protocols in combination with drugs and pharmaceuticals; Scientific research and development, namely, development of scientific methods to enhance brain function, including motor and cognitive functions, in specific brain domains by combining effective brain exercises and training protocols with drugs and pharmaceuticals
Pseudo MarkDART PHARMA; DART PHARMACY

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 23, 2013
Primary Code042
First Use Anywhere DateMonday, August 21, 2017
First Use In Commerce DateMonday, August 21, 2017

Trademark Owner History

Party NameDart NeuroScience, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92131
Party NameDart NeuroScience, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, July 13, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, July 13, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 20, 2017NON-FINAL ACTION E-MAILED
Monday, November 20, 2017SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 25, 2017ASSIGNED TO LIE
Tuesday, October 17, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 12, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 12, 2017NON-FINAL ACTION E-MAILED
Thursday, October 12, 2017SU - NON-FINAL ACTION - WRITTEN
Monday, September 11, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 23, 2017USE AMENDMENT FILED
Wednesday, August 23, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, March 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2017EXTENSION 5 GRANTED
Friday, February 24, 2017EXTENSION 5 FILED
Friday, February 24, 2017TEAS EXTENSION RECEIVED
Tuesday, January 24, 2017ASSIGNED TO EXAMINER
Tuesday, September 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 3, 2016EXTENSION 4 GRANTED
Wednesday, August 17, 2016EXTENSION 4 FILED
Wednesday, August 17, 2016TEAS EXTENSION RECEIVED
Tuesday, March 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 26, 2016EXTENSION 3 GRANTED
Monday, February 22, 2016EXTENSION 3 FILED
Monday, February 22, 2016TEAS EXTENSION RECEIVED
Thursday, February 18, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 18, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 8, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 5, 2015EXTENSION 2 GRANTED
Wednesday, August 26, 2015EXTENSION 2 FILED
Friday, September 4, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 26, 2015TEAS EXTENSION RECEIVED
Wednesday, July 1, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 25, 2015EXTENSION 1 GRANTED
Wednesday, February 25, 2015EXTENSION 1 FILED
Wednesday, February 25, 2015TEAS EXTENSION RECEIVED
Tuesday, August 26, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 31, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 31, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 11, 2014EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, May 16, 2014UNDELIVERABLE MAIL - NO ACTION TAKEN
Wednesday, May 14, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 11, 2014UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, March 21, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 25, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 22, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 22, 2014ASSIGNED TO LIE
Friday, December 27, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 27, 2013EXAMINER'S AMENDMENT ENTERED
Friday, December 27, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 27, 2013EXAMINERS AMENDMENT E-MAILED
Friday, December 27, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, December 26, 2013ASSIGNED TO EXAMINER
Tuesday, September 24, 2013NOTICE OF PSEUDO MARK E-MAILED
Monday, September 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, September 18, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharma dart brain development scientific research domains pharmaceuticals various effective methods deficits